Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis Rats

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Jessup, Jewell A ^a   Lindsey, Sarah H ^a   Wang, Hao ^a   Chappell, Mark C ^a   Groban, Leanne ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G 1; G PROTEIN COUPLED RECEPTOR 30; HORMONE RECEPTOR STIMULATING AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 1 (4 (6 BROMOBENZO(1,3)DIOXOL 5 YL) 3A,4,5,9B TETRAHYDRO 3H CYCLOPENTA(C)QUINOLIN 8 YL)ETHANONE; 1-(4-(6-BROMOBENZO(1,3)DIOXOL-5-YL)-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA(C)QUINOLIN-8-YL)ETHANONE; CYCLOPENTANE DERIVATIVE; G PROTEIN COUPLED RECEPTOR; QUINOLINE DERIVATIVE; REN2 PROTEIN, MOUSE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL SIZE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERTENSION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RNA SEQUENCE; SALT INTAKE; SEQUENCE ANALYSIS; VASCULAR FIBROSIS; ANIMAL; CARDIOMEGALY; DIASTOLE; DRUG EFFECT; DRUG POTENTIATION; ECHOCARDIOGRAPHY; GENETICS; HEART; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; LEWIS RAT; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC RAT;

RATTUS;

ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CYCLOPENTANES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MICE; MYOCARDIUM; QUINOLINES; RATS; RATS, INBRED LEW; RATS, TRANSGENIC; RECEPTORS, G-PROTEIN-COUPLED; RENIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM CHLORIDE, DIETARY;

EID: 78149487334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015433     Document Type: Article

References (55)

1. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, et al. (2001) Importance of heart failure with preserved systolic function in patients. or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 87: 413-419.
2. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, et al. (2003) Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41: 217-223.
3. Solomon SD, Verma A, Desai A, Hassanein A, Izzo J, et al. (2010) Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. Hypertension 55: 241-248.
4. Weinberger MH (1991) Salt sensitivity as a predictor of hypertension. Am J Hypertens 4: 615S-616S.
5. Heimann JC, Drumond S, Alves AT, Barbato AJ, Dichtchekenian V, et al. (1991) Left ventricular hypertrophy is more marked in salt-sensitive than in saltresistant hypertensive patients. J Cardiovasc Pharmacol 17(Suppl 2): S122-S124.
6. Garavaglia GE, Messerli FH, Schmieder RE, Nunez BD, et al. (1989) Sex differences in cardiac adaptation to essential hypertension. Eur Heart J 10: 1110-1114.
7. Dubey RK, Jackson EK (2001) Cardiovascular protective effects of 17betaestradiol metabolites. J Appl Physiol 91: 1868-1883.
8. Pelzer T, Shamim A, Wölfges S, Schumann M, Neyses L (1997) Modulation of cardiac hypertrophy by estrogens. Adv Exp Med Biol 432: 83-89.
9. Grohé C, Kahlert S, Löbbert K, Stimpel M, Karas RH, et al. (1997) Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416: 107-112.
10. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, et al. (2007) Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148: 3236-3245.
11. Revankar CM, Mitchell HD, Field AS, Burai R, Corona C, et al. (2007) Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem Biol 2: 536-544.
12. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, et al. (2008) Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70: 165-190.
13. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
14. Deschamps AM, Murphy E (2009) Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 297: H1806-H1813.
15. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC (2009) Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 150: 3753-3758.
16. Chappell MC, Gallagher PE, Averill DB, Ferrario CM, Brosnihan KB (2003) Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2.Lewis rat. Hypertension 42: 781-786.
17. Chappell MC, Westwood BM, Yamaleyeva LM (2008) Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension. Gend Med 5(Suppl A): S65-S75.
18. Chappell MC, Yamaleyeva LM, Westwood BM (2006) Estrogen and salt sensitivity in the female mRen(2). Lewis rat. Am J Physiol Regul Integr Comp Physiol 291: R1557-R1563.
19. Groban L, Yamaleyeva LM, Westwood BM, Houle TT, Lin M, et al. (2008) Progressive diastolic dysfunction in the female mRen(2). Lewis rat: influence of salt and ovarian hormones. J Gerontol A Biol Sci Med Sci 63: 3-11.
20. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG (2004) Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol 286: H2408-H2415.
21. Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455.
22. Noorlander ML, Melis P, Jonker A, Van Noorden CJ (2002) A quantitative method to determine the orientation of collagen fibers in the dermis. J Histochem Cytochem 50: 1469-1474.
23. Appleton CP (1991) Influence of incremental changes in heart rate on mitral flow velocity: assessment in lightly sedated, conscious dogs. J Am Coll Cardiol 17: 227-236.
24. Choong CY, Herrmann HC, Weyman AE, Fifer MA (1987) Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J Am Coll Cardiol 10: 800-808.
25. Smith SA, Stoner JE, Russell AE, Sheppard JM, Aylward PE (1989) Transmitral velocities measured by pulsed Doppler in healthy volunteers: effects of acute changes in blood pressure and heart rate. Br Heart J 61: 344-347.
26. Stoddard MF, Pearson AC, Kern MJ, Ratcliff J, Mrosek DG, et al. (1989) Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans. Circulation 79: 1226-1236.
27. Dumesnil JG, Paulin C, Pibarot P, Coulombe D, Arsenault M (2002) Mitral annulus velocities by Doppler tissue imaging: practical implications with regard to preload alterations, sample position, and normal values. J Am Soc Echocardiogr 15: 1226-1231.
28. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, et al. (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 102: 1788-1794.
29. Nagueh SF, Kopelen HA, Quiñones MA (1996) Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation 94: 2138-2145.
30. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quiñones MA, et al. (1998) Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation 98: 1644-1650.
31. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, et al. (2006) Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2: 207-212.
32. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, et al. (2003) The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24: 442-463.
33. Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, et al. (2000) Congestive heart failure despite normal left ventricular systolic function in a populationbased sample: the Strong Heart Study. Am J Cardiol 86: 1090-1096.
34. Thohan V, Patel S (2009) The challenges associated with current clinical trials for diastolic heart failure. Curr Opin Cardiol 24: 230-238.
35. Leenen FH, Yuan B (1998) Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. J Hypertens 16: 885-892.
36. Lombardi WL, Gilbert EM (2000) The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure. Curr Cardiol Rep 2: 90-98.
37. Filardo EJ, Thomas P (2005) GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16: 362-367.
38. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, et al. (1998) Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 273: 4883-4891.
39. Holycross BJ, Summers BM, Dunn RB, McCune SA (1997) Plasma renin activity in heart failure-prone SHHF/Mcc-facp rats. Am J Physiol 273: H228-H233.
40. Schunkert H, Danser AH, Hense HW, Derkx FH, Kürzinger S, et al. (1997) Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95: 39-45.
41. Sharkey LC, Holycross BJ, Park S, Shiry LJ, Hoepf TM, et al. (1999) Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failureprone SHHF/Mcc- fa cp rats. J Mol Cell Cardiol 31: 1527-1537.
42. de Jager T, Pelzer T,Müller-Botz S, Imam A, Muck J, et al. (2001) Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements. J Biol Chem 276: 27873-27880.
43. Brosnihan KB, Weddle D, Anthony MS, Heise C, Li P, et al. (1997) Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens 15: 719-726.
44. Nickenig G, Bäumer AT, Grohe C, Kahlert S, Strehlow K, et al. (1998) Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201.
45. Roesch DM, Tian Y, Zheng W, Shi M, Verbalis JG, et al. (2000) Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology 141: 4629-4636.
46. Haugen E, Chen J,Wikström J, Grönros J, Gan LM, et al. (2007) Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats. Int J Cardiol 115: 24.
47. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, et al. (1995) Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96: 1280.
48. Yang CM, Kandaswamy V, Young D, Sen S (1997) Changes in collagen phenotypes during progression and regression of cardiac hypertrophy. Cardiovasc Res 36: 236-245.
49. Xu Y, Arenas IA, Armstrong SJ, Davidge ST (2003) Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res 57: 388-394.
50. Dai Q, Lin J, Craig T, Chou YM, Hinojosa-Laborde C, et al. (2008) Estrogen effects on MMP-13 and MMP-14 regulation of left ventricular mass in Dahl saltinduced hypertension. Gend Med 5: 74-85.
51. Oh JK, Hatle L, Tajik AJ, Little WC (2006) Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 47: 500-506.
52. Dumesnil JG, Paulin C, Pibarot P, Coulombe D, Arsenault M (2002) Mitral annulus velocities by Doppler tissue imaging: practical implications with regard to preload alterations, sample position, and normal values. J Am Soc Echocardiogr 15: 1226-1231.
53. Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS (2001) Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 37: 278-285.
54. Bopassa JC, Eghbali M, Toro L, Stefani E (2010) A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298: H16-H23.
55. Buñag RD (1973) Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34: 279-282.